Edition:
United States

TiVo Corp (TIVO.O)

TIVO.O on Nasdaq

17.90USD
23 Mar 2017
Change (% chg)

$-0.05 (-0.28%)
Prev Close
$17.95
Open
$17.95
Day's High
$18.20
Day's Low
$17.70
Volume
305,032
Avg. Vol
808,961
52-wk High
$23.40
52-wk Low
$15.06

TIVO.O

Chart for TIVO.O

About

TiVo Corporation is engaged in offering media and entertainment products. The Company operates through two segments: Intellectual Property Licensing and Product. The Company's Product segment includes a suite of component technologies that can be integrated into media service provider internally developed platforms or deployed... (more)

Overall

Beta: 0.25
Market Cap(Mil.): $2,174.64
Shares Outstanding(Mil.): 121.15
Dividend: 0.18
Yield (%): 4.01

Financials

  TIVO.O Industry Sector
P/E (TTM): 52.50 41.79 19.76
EPS (TTM): 0.34 -- --
ROI: 1.45 4.28 10.68
ROE: 2.53 5.05 10.31

BRIEF-Tivo partners with Sky to launch voice search

* Tivo partners with Sky to launch voice search Source text for Eikon: Further company coverage:

Mar 22 2017

BRIEF-TiVo CEO Thomas Carson's FY 2016 total compensation $5.9 mln vs $7.6 mln

* CEO Thomas Carson's FY 2016 total compensation $5.9 million versus $7.6 million - SEC filing Source text for Eikon: (http://bit.ly/2mpkykV) Further company coverage:

Mar 14 2017

BRIEF-TiVo posts Q4 earnings per share $0.08

* TiVo Corporation reports fourth quarter and 2016 full year financial results

Feb 15 2017

BRIEF-TiVo and its units enters into refinancing amendment with lenders party

* On January 26, 2017, co and 2 of its units and certain of co's other units entered into refinancing amendment with lenders party, Morgan Stanley senior funding

Jan 26 2017

BRIEF-Orexigen Therapeutics announces spanish launch of Mysimba

* Orexigen Therapeutics announces spanish launch of Mysimba (naltrexone hcl / bupropion hcl prolonged release) in partnership with laboratorios Farmaceuticos Rovi, S.A.

Jan 25 2017

Judge bars TiVo's claim for trade secret damages from Kantar

A federal judge blocked TiVo Research and Analytics on Wednesday from seeking up to $196 million in damages for trade-secret misappropriation and other torts as part of its patent litigation with a rival market-research firm.

Jan 20 2017

BRIEF-TiVo and Netflix enter into product and intellectual property agreements

* TiVo and Netflix enter into product and intellectual property agreements

Nov 28 2016

BRIEF-Samsung and TiVo reach terms on intellectual property agreement

* TiVo Corporation and Samsung Electronics Co Ltd. have agreed to terms regarding a broad intellectual property license

Nov 03 2016

BRIEF-Tivo Corp reports third quarter 2016 financial results

* Tivo Corp - Qtrly earnings per share from continuing operations $ 0.59

Nov 03 2016

BRIEF-Tivo renews product and intellectual property licenses with Panasonic

* Tivo renews product and intellectual property licenses with Panasonic

Oct 31 2016

More From Around the Web

Earnings vs. Estimates